Evidence, Value, Access & Pricing

Trinity Value Center of Excellence

End-to-end strategic partnership through a uniquely integrated combination of market access and HEOR expertise

Creating a compelling value narrative that communicates differentiation to multiple stakeholders can mean favorable access and an optimal price point. 

The challenge is not just in achieving the holistic, compliant value story and fast coverage recommendations—for many U.S. and global access leaders, it lies in pulling through value communication strategy to value communication tools. 

Throughout value work, there are enduring principles that guide value strategy and value communication work:

  • Value is in the eye of the beholder.  
    • Have you considered the drivers and detractors of value for each stakeholder?  
  • A value story must actually be a story.  
    • Is there a coherent narrative that flows through your value proposition?  
    • Does your clinical value messaging tie back to your clinical burden?  
    • Does your health equity messaging align with the core story or create dissonance? 
  • A value story must be succinct.  
    • Have you asked your end users what they need (and don’t need)? Involve them early and be ruthless—short sentences are key. 
  • Value is determined by evidence and country-specific payer drivers.  
    • Have you written your value story “bottom up” (evidence-driven) or “top down” (payer driver-driven)? It needs to be both. 
  • Value stories can and should be innovative, reflecting the new value drivers that have been created by new diseases, technologies and societal priorities.  
    • Have you done the out-of-the-box thinking that your brand needs?  
  • Value stories evolve with the evidence.  
    • Have you prioritized the evidence that will have the most power to strengthen your value story, and fed it into the evidence generation planning process?

The Trinity Advantage

Trinity’s Value Center of Excellence offers partnership along the value journey to U.S./Global Access and HEOR teams, from strategy to communication.   

Trinity approaches value work with a uniquely integrated combination of strategic market access and HEOR expertise. 

HEOR and Medical Experience ensures our work is scientifically rigorous and rooted in evidence. Access Strategy heritage means familiarity with the nuances of life sciences globally -- across lifecycle phases, therapeutic areas, countries and agencies.
HEOR and Medical Experience ensures our work is scientifically rigorous and rooted in evidence. Access Strategy heritage means familiarity with the nuances of life sciences globally -- across lifecycle phases, therapeutic areas, countries and agencies.

We create connection and efficiency between HEOR and Access mindsets and needs because we understand and integrate both.  

We are advisors with context. 

Trinity’s market contextualization is unparalleled in helping clients navigate the commercial environment. Each engagement is built on:   

  • A rich understanding of adjacent functions, such as commercial and medical, to pre-empt dissonance within the client organization 
  • Partnership in navigating payer communications in the U.S. and globally, including workshops and discussion sessions on decisions, implications, trends and challenges at the global/local levels 

We create value propositions that maximize the impact of evidence and provide effective guidance around evidence gaps and mitigation strategies. Our accurate, HEOR-informed medical writing ensures swift, painless medical and legal review. 

We provide end-to-end partnership.

Trinity’s Value COE provides end-to-end partnership from early value concepts to value proposition, U.S./global value dossier and objection handlers.   

  • We offer cross-functional support, from strategy to communication tactics.   
  • We match client needs in terms of speed and expertise with the depth and breadth of our bench of experts. 
  • We are seamlessly connected internally across client engagements to pull through strategic insights 

We optimize value strategy across the product lifecycle.

Defining and optimizing payer value must be executed throughout the product lifecycle as the data and market situation evolves. Depending on asset needs, value propositions can be developed at the aspirational/TPP stage and continually updated through final pivotal and real-world data. Trinity Value creates all the tools needed to shape value strategy and communicate value, including: 

  • Evidence generation and publication to support value communication 
  • Value driver assessment 
  • Early value concept testing 
  • Draft value messaging 
  • Unbranded value deck 
  • Payer value proposition (U.S. or Global) 
  • Messaging testing with key stakeholders (IDIs, dyads, focus groups) 
  • Disease-state educational materials 
  • AMCP dossier development 
  • Global value dossier 
  • Pre-approval Information Exchange (PIE) 
  • Objection handling 
  • Health technology assessment (HTA) 
  • Payer-facing value decks and leave-behinds 
  • Field tools and leave-behinds 
Value Center of Excellence cover

Value Center of Excellence
Brochure

Latest Value Intelligence

Meet Our Value Experts

If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.